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sive calcification were observed more frequently in asymp-
tomatic patients (43 vs 22%; P .014). IPH is significantly
higher in symptomatic plaque regardless of the time since
the neurologic event. For FCR difference between symp-
tomatic and asymtptomatic are significant only during the
first 15 days following the neurological event.
Conclusions: Carotid MRI can identify plaque fea-
tures that are associated with symptomatic presentation and
may be indicative of plaque vulnerability. These features
may ultimately be utilized in the management of extracra-
nial carotid stenosis.
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A Stroke/Vascular Neurology Service Increases the
Volume of Urgent CEAs Performed in a Tertiary Re-
ferral Center
Hernan A. Bazan, Gentry Caton, Sharzad Talebinejad,
Ross Hoffman, Taylor Smith, Elizabeth Holt, Gabriel
Vidal, Kenneth Gaines, W. Charles Sternbergh III.
Ochsner Clinic, New Orleans, LA
Objectives: Patients presenting with carotid-related
acute neurological symptoms are at hightened risk of
stroke. Urgent CEA (uCEA) during the index hospitaliza-
tion is indicated in select patients. We aimed to determine
the effect of a dedicated vascular neurology team on the
volume of uCEAs and assess outcomes.
Methods: CEAs (n436) performed at a tertiary cen-
ter between 2005-2011 were analyzed. Chi-square was
used to compare the uCEA volume pre- (June 2005-Aug.
2008) and post- (Sept. 2008-Nov. 2011) implementation
of a vascular neurology service. Fisher’s exact and t-tests
were used to analyze perioperative outcomes.
Results: The proportion of uCEAs performed in-
creased significantly after initiation of a vascular neurology
service (4.1% [7/172] vs. 22.2% [49/221], P  .0001).
Per annum, uCEAs increased from 5.3% (4/75) in 2005 to
39.6% (25/63) in 2011 (Fig). uCEA indications were
stroke-in-evolution 10% (5/49), crescendo TIAs 6% (3/
49), acute stroke 45% (22/49), and cerebral/ocular TIAs
39% (19/49). Mean National Institutes of Health Stroke
Scale (NIHSS) was 3.5 (0-24); mean TIA score was 5
(1-8). A trend towards a higher combined stroke/death
rate in the urgent compared to the elective symptomatic
CEA group group was present (7.1 % [3/49] vs. 2% [1/
49]; p .36); however, patients undergoing uCEAwith an
NIHSS10 had no perioperative complications.
Conclusions: Collaboration with a vascular neurology
team increased the volume of uCEAs over a three year
period. In patients with mild strokes (NIHSS10), uCEA
outcomes approximate those for electively-performed
CEAs.
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Florida, Gainesville, FL
Objectives: SCI is a devastating complication of TE-
VAR with varying degrees of disability. Here we review the
outcomes of patients with SCI after TEVAR.
Methods: Patients with SCI after TEVAR, defined
by any lower extremity neuro deficit over baseline, were
evaluated. A database query and chart review/phone
interviews with patients/family were used to determine
outcomes and functional status after discharge. Patients
were analyzed based on functional recovery and timing
of their CSF drain placement(prophylactic or post-op for
symptoms).
Results: 609 TEVARs were performed in the study
period, and 57 patients developed SCI (9.4%). In-hospital
mortality with SCI was 7.0%. 54 patients (95%) had a CSF
drain placed with the majority placed post-op (54%). Com-
plete data were available for 34 patients (60%) of whom 27
(47%) were alive at follow-up[median 11.8mos]. Of these
34 patients, 26 (76%) had functional improvement, with 12
(35%) reporting return to baseline. Survival was worse in
patients with no functional improvement (NI) when com-
pared to patients with improvement (WI). Median survival
for WI patients was 56mos compared to 3mos (P.001) in
NI patients. No difference in functional improvement or
Fig. *September 2008: Vascular neurology service implementa-
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mortality was noted when comparing patients with prophy-
lactic vs. post-op drains.
Conclusions: SCI can be a devastating complication
after TEVAR and patients without functional improvement
have a dismal prognosis. Measures to decrease the rate of
SCI and/or mitigate its severity are needed. Timing of
drain placement does not appear to have an impact on
functional recovery.
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Outcomes following Late Explantation of Aortic En-
dografts Depend on the Indication
Shipra Arya1, DawnM. Coleman1, Jordan Knepper1, Peter
K. Henke1, Gilbert R. Upchurch2, John E. Rectenwald1,
Enrique Criado1, Jonathan L. Eliason1, Katherine Gal-
lagher1. 1Vascular Surgery, University of Michigan, Ann
Arbor, MI; 2University of Virginia, Charlottesville, VA
Objectives: This study compares our experience with
explantation of aortic endografts for endoleak versus
infection.
Methods: The medical records of 1500 aortic proce-
dures performed at our center were queried from 2002-
2011. Relevant data from patients needing explantation of
aortic endografts was analyzed.
Results: 36 patients underwent aortic explantation
(63.9% male). Mean age was 71.6 years with a mean aneu-
rysm size of 6.6cm (range 3.5 - 10.7cm). Hypertension
(97%), hyperlipidemia (77.8%) and smoking (83%) were
the most prevalent risk factors. Mean time to explant was
45.3 months (range 2.2- 118.4 months). The primary
explant indication was endoleak in 24 (66.7%) and infec-
tion in 12 (33.3%) patients. Thirty-day morbidity was
54%(endoleak) and 83%(infection). There were 2
deaths(16.7%) in the infection group within 30 days. Five
patients were symptomatic, while 2 patients had ruptured
aneurysms. In the endoleak group, there were 9 type Ia, 7
type II, 1 type III, 3 type V, 1 rupture and 3 patients with
multiple endoleaks. 78% of patients were alive at a mean
follow-up of 17. 4 months.
Conclusions:This is the largest endograft explantation
series to date. Patients with an infectious etiology have
significantly worse morbidity and mortality than patients
requiring explantation for endoleaks.
Table. Peri-operative variables by indication for explant
Peri-operative variable
Endoleak
(n  24)
Infection
(n  12)
Males (%) 50.0 91.7a
ASA class  3 at explant (%) 50.0 66.7a
Supra-mesenteric clamping (%) 4.4 50.0a
Re-exploration needed (%) 4.2 41.7a
Post-op DIC (%) 0 25.0a
30-day mortality (%) 0 16.7
Intra-op blood loss (Liters) 3.3 6.3a
Mean PRBCs transfused intra-op (n) 4.3 12.2a
ICU length of stay (days) 5.4 10.4
Length of stay (days) 12.2 18.7
ASA, American Society of Anesthesiologists; DIC, disseminated intravascu-
lar coagulation; ICU, intensive care unit
aP0.05
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Primary Balloon Angioplasty of Small (<2 mm) Ce-
phalic Veins Shortens Maturation Time, Decreases Re-
interventions and Improves Mid-term Patency of Arte-
riovenous Fistulae
Pierfrancesco Veroux1, Tiziano Tallarita1, Alessia Gi-
aquinta1, Peter Gloviczki2, Massimiliano Veroux1. 1Poli-
clinico of Catania, Catania, Italy; 2Mayo Clinic, Rochester,
MN
Objectives:To evaluate the novel technique of Primary
Balloon Angioplasty (PBA) of cephalic veins with diameter
2mm on patency of radio-cephalic arteriovenous fistulae
(AVF) before performing the anastomosis.
Methods: Forty patients, all candidates for distal radio-
cephalic fistula, with a cephalic vein2 mm, were random-
ized to undergo dilatation of the cephalic veins with two
different techniques, before performing the anastomosis:
A) PBA of a long cephalic vein segment from the wrist up to
the elbow (n19); B) hydrostatic dilatation (HD) of a
short venous segment (5cm) at the level of the anastomosis
(n21). PBA was performed using a Pacific Extreme
Fig.
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